Jeil Pharma Holdings Inc (KRX:002620)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,680.00
+70.00 (0.92%)
At close: Sep 11, 2026

Jeil Pharma Holdings Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
630,891657,614779,822804,043792,965762,568
Revenue Growth
-14.26%-15.67%-3.01%1.40%3.99%0.07%
Gross Profit
256,690253,498206,521214,584180,483180,507
Operating Income
18,61038,986-11,18120,920-7,548-8,975
Net Income
8,43514,635-51,159-16,250-74,556-3,482
Earnings Per Share
549.37953.37-3333.00-1059.00-4857.00-227.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
87,50579,31275,88359,13153,40347,224
Total Debt
184,738167,369155,212214,143162,616115,072
Net Cash (Debt)
-97,234-88,058-79,329-155,012-109,213-67,848
Net Cash Growth
------
Net Cash Per Share
-6333.98-5736.24-5168.22-10097.73-7114.36-4419.76

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
11,861390.264,542-4,416-17,25613,403
Capital Expenditures
-12,764-8,283-4,340-6,223-15,462-23,688
Free Cash Flow
-902.83-7,893202.38-10,638-32,717-10,284
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
40.69%38.55%26.48%26.69%22.76%23.67%
Operating Margin
2.95%5.93%-1.43%2.60%-0.95%-1.18%
Pretax Margin
3.91%5.99%-7.90%-1.74%-10.58%-0.80%
Profit Margin
1.34%2.23%-6.56%-2.02%-9.40%-0.46%
FCF Margin
-0.14%-1.20%0.03%-1.32%-4.13%-1.35%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
50.000--50.00050.00065.000
Dividend Per Share Growth
40.00%--0%-23.08%-7.14%
Dividend Yield
0.66%--0.43%0.33%0.42%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13.988.43----
P/FCF Ratio
--593.17---
PS Ratio
0.190.190.150.230.300.32